Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Health news
  • Doctor News
  • Delhi HC restrains IVF...

Delhi HC restrains IVF Specialist, Angel Investor from posting defamatory content against WhiteHat Jr

Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-11-25T12:30:34+05:30  |  Updated On 25 Nov 2020 12:30 PM IST
Delhi HC restrains IVF Specialist, Angel Investor from posting defamatory content against WhiteHat Jr
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: The Delhi High Court recently passed an ad interim order against a doctor, restraining him from posting or sharing any derogatory content against rival edutech platform, WhiteHat Jr., owned by BYJU's.

The court, on Tuesday, ordered the IVF Specialist, Dr Aniruddha Malpani, who funds early-stage start-ups, from posting any derogatory content which defames or deprecates WhiteHat Education Technology Pvt Ltd, a start-up that teaches coding to children.

The direction was issued by Justice Mukta Gupta who also issued summons to the doctor in the suit filed against him by WhiteHat seeking a permanent injunction restraining him from defaming it, infringing, diluting, or tarnishing its trademark and seeking damages of around Rs 14 crore from him.

Also Read: Regulation Of Unauthorized Path Labs: PIL Seeks Delhi HC To Direct Implementation Of Health Bill 2019

The court also directed Malpani to take down, within 48 hours, certain tweets which according to it were deprecatory. In these tweets, Malpani had called WhiteHat Jr a "racket", compared it to a pig, and accused it of being shameless and stealing from code.org and so on.

Taking note of the same, WhiteHat filed had filed a defamation lawsuit stating that the doctor's tweets were defamatory and tarnishes the image of the company as well as the tutors employed by it to teach coding to children. The suit also alleges infringement of trademark and passing off.

Appearing for WhiteHat Jr, Senior Advocate Neeraj Kishan Kaul argued that Malpani, an investor in rival edutech businesses, had launched a slanderous campaign against the platform on social media.

"There is completely disparaging tweeting and reporting on our business model..No one is denying free speech. The problem is when you cross the Laxman Rekha of fair criticism," he said.

Referring to a series of tweets in which Malpani called WhiteHat Jr a liar, a cheat, a slimy hypocrite, and other objectionable names, Kaul asserted that the endeavour was to bring down a business that targeted the same audience.

Kaul submitted that while the free speech was at the heart of democracy, the same did not protect disparagement.

He also pointed out that the 'right to reputation' was a protected right under Article 21 of the Constitution and the Right to Privacy.

As per a recent report by Bar and Bench, Advocates Rajashekhar Rao and Shwetasree Majumdar supplemented Kaul and urged the court to look at Malpani's conduct and tweets after an order was passed against another person in a similar matter, Pradeep Poonia.

Wolf Gupta is finally unmasked!#WhiteHatJr needs to stop preying on Indian children. If you don't want them to end up as Little Red Riding Hood, please speak up! #whiteHatJrScam pic.twitter.com/I7DS1c0rkS

— Aniruddha Malpani (@malpani) November 23, 2020

On the other hand, Malpani's counsel contended in court that the suit was an "attempt by a billion-dollar behemoth to muzzle free speech".

advocate Yadunath Bhargavan representing Malpani asserted that Malpani was a highly educated person, to which the Court replied:

"How does it matter? The most illiterate person can be the most well mannered..deal with everybody.. for me everyone is the same."

Bhargavan explained the submission was made in light of the allegation of cancellation of license by Maharashtra Medical Council. The court, however, said that the same was beyond the scope of the present case.

Defending Malpani's comments and statements on Twitter, Bhargavan remarked,

"Here's a 12 billion dollar start-up saying it will not take dissent.."

Bhargavan further asserted that since the plaintiff (WhiteHat Jr) and the defendant (Malpani) reside in Mumbai, the suit was not maintainable in Delhi.

In response to Malpani's counsel's submissions regarding his client's extensive educational qualification, the court said, "there has to be a difference between healthy and abusive discussion".

It also said that education does not guarantee good manners, as even the most illiterate person can be well-mannered.

During the course of the hearing, the court also made some pertinent remarks on the functioning of social media platform, Twitter as;

"On social media, people are encouraged to speak unsubstantiated.. you retweet something thinking it is a gospel truth,"

The Court added,

"I cannot get out of the fact that he's retweeting posts of a person he doesn't know.. and still, stake claims that I'm right.."

As a prima facie opinion, the court held that irreparable harm would be caused to WhiteHat Jr if an ad-interim injunction is not granted.

Stating that the balance of convenience was in favor of WhiteHat Jr, the court restrained Malpani from making any further disparaging comments.

The court also issued summons to Malpani in the suit and the interim application. The matter would be heard next on January 14, reports Bar and Bench.

Delhi High CourtWhiteHat Education Technology Pvt Ltdivf specialistangel investorwhitehat jraniruddha malpanibyjusBYJU
Source : with agency inputs
Medical Dialogues Bureau
Medical Dialogues Bureau

    Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    High Blood Pressure in Children Tied to Mothers Pregnancy Health: NIH Study Finds

    High Blood Pressure in Children Tied to Mother's Pregnancy Health: NIH Study Finds

    View All

    Health News Today

    Health Bulletin 10/ May/ 2025

    Health Bulletin 10/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok